Neuroage Therapeutics: Revolutionary Brain Health Test Predicts Dementia Risk 30 Years In Advance
Neuroage Therapeutics: Revolutionary Brain Health Test Predicts Dementia Risk 30 Years In Advance . (MENAFN - GlobeNewsWire - Nasdaq) A Breakthrough Prognostic for Tracking Brain Aging to Maintain Cognitive ResilienceSAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- NeuroAge Therapeutics unveiled ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108925297/Neuroage-Therapeutics-Revolutionary-Brain-Health-Test-Predicts-Dementia-Risk-30-Years-In-Advance
2024-11-25
rss
(MENAFN - GlobeNewsWire - Nasdaq) A Breakthrough Prognostic for Tracking Brain Aging to Maintain Cognitive ResilienceSAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- NeuroAge Therapeutics unveiled ...
Neuroage Therapeutics: Revolutionary Brain Health Test Predicts Dementia Risk 30 Years In Advance